Fig. 80From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease3D docking model of C92 with TcAChE (a, b) [9]Back to article page
